Advertisement

Journal of Physiology and Biochemistry

, Volume 75, Issue 3, pp 275–283 | Cite as

Effects of resveratrol and its analogue pterostilbene, on NOV/CCN3 adipokine in adipose tissue from rats fed a high-fat high-sucrose diet

  • J. Trepiana
  • S. Gómez-Zorita
  • Alfredo Fernández-QuintelaEmail author
  • M. González
  • M. P. Portillo
Original Article

Abstract

Nephroblastoma overexpressed protein, also called NOV/CCN3, is an adipokine which is present in various tissues and recently linked to obesity. The objective of the study was to determine the effect of resveratrol and pterostilbene on NOV/CCN3 in adipose tissue from rats fed an obesogenic diet. Thirty-six male Wistar rats were split into four groups (n = 9): fed a standard diet (CC), high-fat high-sucrose (HFS) diet supplemented with resveratrol (RSV; 30 mg/kg/day) or with pterostilbene (PT; 30 mg/kg/day), or without phenolic supplementation (HFS). Rats were sacrificed after 6 weeks of treatment, and adipose tissue (white and brown) from different anatomical locations were dissected. Then, Nov/ccn3 gene and protein expression and the adipogenic genes, Ucp-1 and Pgc-1a, expressions were studied. Increased weight of white adipose tissues was found in rats fed the HFS diet. Whereas resveratrol-treated rats showed reduced internal and total adipose tissue weights, pterostilbene-treated rats showed reduced subcutaneous, internal and total adipose depots. Nov/ccn3 gene expression decreased in epididymal and interscapular brown depot in rats fed HFS diet when compared with the control group. Regarding the phenolic compounds, resveratrol prompted a Nov/ccn3 gene expression increase in epididymal fat tissue, whereas pterostilbene reduced its protein expression compared with the obese group. However, these phenolic compounds did not affect NOV/CCN3 expression in brown depot. NOV/CCN3 seems to be involved in weight changes in epididymal adipose tissue under obesogenic feeding, but not in subcutaneous, acting as a protective mechanism counteracting the fattening effect of the diet. To our knowledge, this is the first study analyzing whether NOV/CCN3 is involved in the anti-obesity effect of resveratrol and pterostilbene. Our results suggest that this is not the case.

Keywords

NOV/CCN3 Resveratrol Pterostilbene Phenolic compounds Adipose tissue Obesity 

Notes

Funding information

This study was supported by grants from the Instituto de Salud Carlos III (CIBERObn), Government of the Basque Country (IT-572-13).

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Aguirre L, Milton-Laskibar I, Hijona E, Bujanda L, Rimando AM, Portillo MP (2016) Effects of pterostilbene in brown adipose tissue from obese rats. J Physiol Biochem 73:457–464.  https://doi.org/10.1007/s13105-017-0556-2 CrossRefPubMedGoogle Scholar
  2. 2.
    Aguirre L, Fernandez-Quintela A, Arias N, Portillo MP (2014) Resveratrol: anti-obesity mechanisms of action. Molecules 19:18632–18655.  https://doi.org/10.3390/molecules191118632 CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Andrade JM, Frade AC, Guimaraes JB, Freitas KM, Lopes MT, Guimaraes AL, de Paula AM, Coimbra CC, Santos SH (2014) Resveratrol increases brown adipose tissue thermogenesis markers by increasing SIRT1 and energy expenditure and decreasing fat accumulation in adipose tissue of mice fed a standard diet. Eur J Nutr 53:1503–1510.  https://doi.org/10.1007/s00394-014-0655-6 CrossRefPubMedGoogle Scholar
  4. 4.
    Bjorndal B, Burri L, Staalesen V, Skorve J, Berge RK (2011) Different adipose depots: their role in the development of metabolic syndrome and mitochondrial response to hypolipidemic agents. J Obes 2011:490650.  https://doi.org/10.1155/2011/490650 CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Bonet ML, Mercader J, Palou A (2017) A nutritional perspective on UCP1-dependent thermogenesis. Biochimie 134:99–117CrossRefPubMedGoogle Scholar
  6. 6.
    Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254CrossRefGoogle Scholar
  7. 7.
    Deveaud C, Beauvoit B, Salin B, Schaeffer J, Rigoulet M (2004) Regional differences in oxidative capacity of rat white adipose tissue are linked to the mitochondrial content of mature adipocytes. Mol Cell Biochem 267:157–166CrossRefPubMedGoogle Scholar
  8. 8.
    Escote X, Gomez-Zorita S, Lopez-Yoldi M, Milton-Laskibar I, Fernandez-Quintela A, Martinez JA, Moreno-Aliaga MJ, Portillo MP (2017) Role of omentin, vaspin, cardiotrophin-1, TWEAK and NOV/CCN3 in obesity and diabetes development. Int J Mol Sci 18.  https://doi.org/10.3390/ijms18081770
  9. 9.
    Feve B, Bastard C, Fellahi S, Bastard JP, Capeau J (2016) New adipokines. Ann Endocrinol (Paris) 77:49–56.  https://doi.org/10.1016/j.ando.2016.01.001 CrossRefGoogle Scholar
  10. 10.
    Gomez-Zorita S, Fernandez-Quintela A, Lasa A, Aguirre L, Rimando AM, Portillo MP (2014) Pterostilbene, a dimethyl ether derivative of resveratrol, reduces fat accumulation in rats fed an obesogenic diet. J Agric Food Chem 62:8371–8378.  https://doi.org/10.1021/jf501318b CrossRefPubMedGoogle Scholar
  11. 11.
    Holbourn KP, Acharya KR, Perbal B (2008) The CCN family of proteins: structure-function relationships. Trends Biochem Sci 33:461–473.  https://doi.org/10.1016/j.tibs.2008.07.006 CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Jia Q, Dong Q, Qin L (2016) CCN: core regulatory proteins in the microenvironment that affect the metastasis of hepatocellular carcinoma? Oncotarget 7:1203–1214.  https://doi.org/10.18632/oncotarget.6209 CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Joseph JA, Fisher DR, Cheng V, Rimando AM, Shukitt-Hale B (2008) Cellular and behavioral effects of stilbene resveratrol analogues: implications for reducing the deleterious effects of aging. J Agric Food Chem 56:10544–10551.  https://doi.org/10.1021/jf802279h CrossRefPubMedGoogle Scholar
  14. 14.
    Kular L, Pakradouni J, Kitabgi P, Laurent M, Martinerie C (2011) The CCN family: a new class of inflammation modulators? Biochimie 93:377–388.  https://doi.org/10.1016/j.biochi.2010.11.010 CrossRefPubMedGoogle Scholar
  15. 15.
    Lin Z, Natesan V, Shi H, Hamik A, Kawanami D, Hao C, Mahabaleshwar GH, Wang W, Jin ZG, Atkins GB, Firth SM, Rittie L, Perbal B, Jain MK (2010) A novel role of CCN3 in regulating endothelial inflammation. J Cell Commun Signal 4:141–153.  https://doi.org/10.1007/s12079-010-0095-x CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods 25:402–408.  https://doi.org/10.1006/meth.2001.1262 CrossRefGoogle Scholar
  17. 17.
    Martinerie C, Garcia M, Do TT, Antoine B, Moldes M, Dorothee G, Kazazian C, Auclair M, Buyse M, Ledent T, Marchal PO, Fesatidou M, Beisseiche A, Koseki H, Hiraoka S, Chadjichristos CE, Blondeau B, Denis RG, Luquet S, Feve B (2016) NOV/CCN3: a new adipocytokine involved in obesity-associated insulin resistance. Diabetes 65:2502–2515.  https://doi.org/10.2337/db15-0617 CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Mattison JA, Wang M, Bernier M, Zhang J, Park SS, Maudsley S, An SS, Santhanam L, Martin B, Faulkner S, Morrell C, Baur JA, Peshkin L, Sosnowska D, Csiszar A, Herbert RL, Tilmont EM, Ungvari Z, Pearson KJ, Lakatta EG, de Cabo R (2014) Resveratrol prevents high fat/sucrose diet-induced central arterial wall inflammation and stiffening in nonhuman primates. Cell Metab 20:183–190.  https://doi.org/10.1016/j.cmet.2014.04.018 CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Nakamura K, Fuster JJ, Walsh K (2014) Adipokines: a link between obesity and cardiovascular disease. J Cardiol 63:250–259.  https://doi.org/10.1016/j.jjcc.2013.11.006 CrossRefPubMedGoogle Scholar
  20. 20.
    Pakradouni J, Le Goff W, Calmel C, Antoine B, Villard E, Frisdal E, Abifadel M, Tordjman J, Poitou C, Bonnefont-Rousselot D, Bittar R, Bruckert E, Clement K, Feve B, Martinerie C, Guerin M (2013) Plasma NOV/CCN3 levels are closely associated with obesity in patients with metabolic disorders. PLoS One 8:e66788.  https://doi.org/10.1371/journal.pone.0066788 CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Palou M, Priego T, Sanchez J, Rodriguez AM, Palou A, Pico C (2009) Gene expression patterns in visceral and subcutaneous adipose depots in rats are linked to their morphologic features. Cell Physiol Biochem 24:547–556.  https://doi.org/10.1159/000257511 CrossRefPubMedGoogle Scholar
  22. 22.
    Paradis R, Lazar N, Antinozzi P, Perbal B, Buteau J (2013) Nov/Ccn3, a novel transcriptional target of FoxO1, impairs pancreatic beta-cell function. PLoS One 8:e64957.  https://doi.org/10.1371/journal.pone.0064957 CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Perbal B (1995) Pathogenic potential of myeloblastosis-associated viruses. Infect Agents Dis 4:212–227PubMedGoogle Scholar
  24. 24.
    Su BY, Cai WQ, Zhang CG, Martinez V, Lombet A, Perbal B (2001) The expression of ccn3 (nov) RNA and protein in the rat central nervous system is developmentally regulated. Mol Pathol 54:184–191CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Szkudelski T, Szkudelska K (2015) Resveratrol and diabetes: from animal to human studies. Biochim Biophys Acta 1852:1145–1154.  https://doi.org/10.1016/j.bbadis.2014.10.013 CrossRefPubMedGoogle Scholar
  26. 26.
    Thibout H, Martinerie C, Creminon C, Godeau F, Boudou P, Le Bouc Y, Laurent M (2003) Characterization of human NOV in biological fluids: an enzyme immunoassay for the quantification of human NOV in sera from patients with diseases of the adrenal gland and of the nervous system. J Clin Endocrinol Metab 88:327–336.  https://doi.org/10.1210/jc.2002-020304 CrossRefPubMedGoogle Scholar
  27. 27.
    Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB (1999) Elevated C-reactive protein levels in overweight and obese adults. JAMA 282:2131–2135CrossRefPubMedGoogle Scholar

Copyright information

© University of Navarra 2019

Authors and Affiliations

  1. 1.Nutrition and Obesity Group, Department of Nutrition and Food ScienceUniversity of the Basque Country (UPV/EHU) and Lucio Lascaray Research InstituteVitoriaSpain
  2. 2.Biomedical Research Networking Centres, Physiopathology of Obesity and Nutrition (CIBERobn)Institute of Health Carlos IIIMadridSpain
  3. 3.Department Nutrición y Bromatología, Facultad de FarmaciaPaseo de la Universidad 7VitoriaSpain
  4. 4.Nutrition and Food Science Department, Faculty of Biochemistry and Biological SciencesNational University of Litoral and National Scientific and Technical Research Council (CONICET)Santa FeArgentina

Personalised recommendations